The Effect of Berries on Lung Cancer Tumors
NCT00681512 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2018-02-06
Summary
The purpose of this study is to determine how berries affect cancer tumors in patients with non-small cell lung cancer.
Conditions
- Non Small Cell Lung Cancer
Interventions
- DIETARY_SUPPLEMENT
-
berry powder
All subjects (lung cancer survivors and volunteers) will consume 20 grams of berry powder (blueberries, black raspberries, or a mixture of both) per day by mouth for the first 3 days, then 40 grams of berry powder by mouth every day for 4 to 5 weeks. The berry powder is to be mixed in subject's routine intake of milk, yogurt, juice, or water. All subjects will have the option to continue the berry regimen for an extended period. Subjects who choose to do so will not consume any berry powder for one week. After one week, subjects will begin consuming 40 grams of the berry powder every day for an additional 4 to 5 weeks.
Sponsors & Collaborators
-
James Graham Brown Cancer Center
collaborator OTHER -
University of Louisville
lead OTHER
Principal Investigators
-
Ramesh Gupta, PhD · James Graham Brown Cancer Center
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy
NCT02152059 ·Status: WITHDRAWN ·Phase: PHASE2
-
Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma
NCT05303493 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer
NCT01820325 ·Status: TERMINATED ·Phase: PHASE1
-
Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)
NCT01487499 ·Status: TERMINATED ·Phase: PHASE3
-
Dietary Intervention for NSCLC Patients Treated With ICI
NCT05805319 ·Status: RECRUITING ·Phase: NA
-
Induction Chemo-Nivo in Unresectable Stage III NSCLC
NCT06003075 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
NCT00073151 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer
NCT00308529 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer
NCT00075751 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
NCT01222572 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).
NCT00760929 ·Status: TERMINATED ·Phase: PHASE2
-
ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer
NCT00132379 ·Status: COMPLETED ·Phase: PHASE1
-
Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC
NCT00226590 ·Status: COMPLETED ·Phase: PHASE2
-
An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT01711697 ·Status: UNKNOWN ·Phase: PHASE1
-
BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)
NCT00656136 ·Status: COMPLETED ·Phase: PHASE3
-
Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung Cancer
NCT02937402 ·Status: TERMINATED ·Phase: NA
-
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
NCT06800339 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
NCT03093909 ·Status: RECRUITING ·Phase: PHASE1
-
Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC
NCT05691829 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer
NCT00707252 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.
NCT00042679 ·Status: COMPLETED ·Phase: PHASE2
-
S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer
NCT00074295 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
NCT01770418 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00059761 ·Status: COMPLETED ·Phase: PHASE1
-
Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer
NCT00449020 ·Status: COMPLETED ·Phase: PHASE2